Skip to content

RNTX RNTX EPS (Diluted)

EPS (Diluted) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.31+9.2%
Gilead Sciences logo
Gilead SciencesGILD
$1.61+54.8%
AbbVie logo
AbbVieABBV
$0.39-45.8%
CTO
Citius Oncology, Inc.CTOR
-$0.27-145%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$0.11+35.3%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-$0.10

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's EPS (diluted)?
RNTX (RNTX) reported EPS (diluted) of -$0.19 in Q1 2026.
How has RNTX's EPS (diluted) changed year-over-year?
RNTX's EPS (diluted) increased by 24.0% year-over-year, from -$0.25 to -$0.19.
What is the long-term trend for RNTX's EPS (diluted)?
Over 4 years (2021 to 2025), RNTX's EPS (diluted) has grown at a -24.0% compound annual growth rate (CAGR), from -$5.88 to -$1.96.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.